Translate page

English English
en Englishbg Bulgarianzh-CN Chinese (Simplified)hr Croatiancs Czechda Danishnl Dutchfi Finnishfr Frenchde Germanel Greekiw Hebrewhi Hindiid Indonesianit Italianja Japaneseko Koreanmk Macedonianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsv Swedishth Thaitr Turkishvi Vietnamese

Haematopoietic stem cell transplantation after reduced intensity conditioning in children and adolescents with CML: A prospective multicentre trial of the I-BFM Study Group (Pichler H et al. Br J Haematol, May 2024)

Haematopoietic stem cell transplantation after reduced intensity conditioning in children and adolescents with CML: A prospective multicentre trial of the I-BFM Study Group
Pichler H et al. Br J Haematol, May 2024 (epub ahead of print)
– open access publication

Link to full abstract


 

 

 

 

Priapism and chronic myeloid leukemia in an adolescent. Rare debut presentation. A case report (Romero-Guerra AL et al. Arch Argent Pediatr, April 2024)

Priapism and chronic myeloid leukemia in an adolescent. Rare debut presentation. A case report.
Romero-Guerra AL et al. Arch Argent Pediatr, April 2024
– open access publication
 
Link to full abstract


 

 

 

 

 

 

Imatinib treatment and longitudinal growth in pediatric patients with CML: Influence of demographic, pharmacological, and genetic factors in the German CML-PAED Cohort (Stiehler S et al. Haematologica, March 2024)

Imatinib treatment and longitudinal growth in pediatric patients with chronic myeloid leukemia: Influence of demographic, pharmacological, and genetic factors in the German CML-PAED Cohort
Stiehler S et al. Haematologica, March 2024 (epub ahead of print) – open access publication
  
Link to full abstract


 

 

 

 

 

 

Somatic variant profiling in chronic phase pediatric chronic myeloid leukemia (Behrens YL et al. Haematologica, March 2024)

Somatic variant profiling in chronic phase pediatric chronic myeloid leukemia
Behrens YL et al. Haematologica, March 2024 – open access publication

Link to full abstract


 

 

 

 

 

 

Predictive value of early molecular response to tyrosine kinase inhibitors in pediatric patient with chronic myeloid leukemia

Predictive value of early molecular response to tyrosine kinase inhibitors in pediatric patient with chronic myeloid leukemia
Abdallah AM et al. Leuk Lymphoma, March 2024 (epub ahead of print)
  
Link to full abstract


 

 

 

 

 

 

  1. Chronic spontaneous urticarial as the presenting factor in a paediatric case of chronic myeloid leukemia (Sutton KM et al. Pediatr Blood Cancer, March 2024)
  2. Bosutinib in resistant and intolerant pediatric patients with chronic phase CML: Results from the Phase I part study ITCC054/COG AMML1921 (Brivio E et al. J Clin Oncol, March 2024)
  3. A 3-year old with chronic myeloid leukemia (Coty-Fatall Z & Richardson A. Blood, February 2024)
  4. Challenges in management of pediatric chronic myleloid leukemia (pCML) in the low- and middle income countries (LMICs): Insights from an Interntional CML Foundation (iCMLf) Multi National Study (Roy Moulik N et al. Pediatr Hematol Oncol, Jan 2024)